Barclays Raises Procter & Gamble (NYSE:PG) Price Target to $170.00

Procter & Gamble (NYSE:PG) had its price objective upped by equities researchers at Barclays from $168.00 to $170.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price target points to a potential upside of 5.56% from the company’s previous close.

Other equities research analysts have also recently issued research reports about the company. UBS Group upped their price target on Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a report on Wednesday, January 24th. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and upped their target price for the company from $160.00 to $175.00 in a research note on Monday, March 11th. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Deutsche Bank Aktiengesellschaft reduced their target price on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday. Finally, Raymond James upped their target price on Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $168.88.

Procter & Gamble Stock Performance

NYSE PG traded up $0.50 on Tuesday, hitting $161.04. 2,059,832 shares of the company’s stock were exchanged, compared to its average volume of 6,893,167. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.69 and a quick ratio of 0.48. The firm’s 50-day moving average price is $159.21 and its two-hundred day moving average price is $153.13. Procter & Gamble has a fifty-two week low of $141.45 and a fifty-two week high of $163.14. The firm has a market cap of $378.93 billion, a price-to-earnings ratio of 26.33, a P/E/G ratio of 3.19 and a beta of 0.44.

Procter & Gamble (NYSE:PG) last released its earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. The company had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a return on equity of 33.77% and a net margin of 18.00%. The firm’s quarterly revenue was up .6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.37 EPS. On average, research analysts expect that Procter & Gamble will post 6.53 EPS for the current year.

Insider Buying and Selling at Procter & Gamble

In other news, insider Marc S. Pritchard sold 101,704 shares of Procter & Gamble stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $153.57, for a total transaction of $15,618,683.28. Following the sale, the insider now directly owns 163,428 shares of the company’s stock, valued at $25,097,637.96. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, CEO Ma. Fatima Francisco sold 74,443 shares of the business’s stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $153.30, for a total value of $11,412,111.90. Following the completion of the sale, the chief executive officer now directly owns 973 shares of the company’s stock, valued at $149,160.90. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Marc S. Pritchard sold 101,704 shares of the business’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.57, for a total value of $15,618,683.28. Following the completion of the sale, the insider now directly owns 163,428 shares of the company’s stock, valued at $25,097,637.96. The disclosure for this sale can be found here. Insiders have sold 279,063 shares of company stock valued at $43,187,745 over the last three months. 0.17% of the stock is owned by company insiders.

Hedge Funds Weigh In On Procter & Gamble

A number of hedge funds and other institutional investors have recently bought and sold shares of PG. Advantage Trust Co acquired a new position in Procter & Gamble in the fourth quarter valued at approximately $28,000. Wyrmwood Management LLC acquired a new position in Procter & Gamble in the fourth quarter valued at approximately $29,000. Naples Money Management LLC acquired a new position in Procter & Gamble in the fourth quarter valued at approximately $29,000. Transcendent Capital Group LLC acquired a new position in Procter & Gamble in the fourth quarter valued at approximately $31,000. Finally, Criterion Capital Advisors LLC acquired a new position in Procter & Gamble in the fourth quarter valued at approximately $33,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.